cipepofol · Haisco · NDA 220482
Cypsedo
Earliest generic entry, as listed
6 May 2034
Blocked by patent: US 10729666, US 9517988.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10729666 | drug product, use U-4599 · sets the listed date | 6 May 2034 |
| US 9517988 | drug substance, use U-4599 · sets the listed date | 6 May 2034 |
Exclusivities · 1 unexpired
| NCE | new chemical entity (5 years) | 27 Aug 2031 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 220482 · 001 · RLD | emulsion, intravenous | 50MG/20ML (2.5MG/ML) | 6 May 2034 |